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Abstract
Context: Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) is one of the world’s most 
challenging pandemics. For treatment with Highly Active Anti-Retroviral Therapy (HAART) to be effective, high rate of 
adherence is essential.
Aim: To demonstrate the effect of adherence counseling and text message reminders in improving patients’ adherence 
to HAART.
Settings and Design: A randomized control trial among non-adherents was carried out in a tertiary hospital in Nigeria 
between March and July, 2011.
Materials and Methods: A total of 104 patients: 45 males (43.3%) and 59 females (56.7%) participated in the study. 
They were randomized into intervention and control groups. The intervention group received monthly adherence 
counseling and twice weekly short message reminders for four months, while the control group received only standard 
care. Self-reported adherence and CD4+ cell counts were measured pre- and post-intervention.
Statistical Analysis Used: Data was analysed using Statistical Package for Social Sciences (SPSS) version 18. Risk 
rates, Chi-square, Mann-Whitney U test and Cohen’s effect size were calculated. Level of significance was set at P = 0.05.
Results: At post-intervention, 76.9% of the intervention group and 55.8% of the control group achieved adherence 
(χ2 = 5.211, P = 0.022, RR = 0.75 (0.55-0.96), Cohen’s w = 0.224). Also, median CD4+ cell count of the intervention group 
increased from 193 cells/ml to 575.0 cells/ml against 131.0 cells/ml to 361.5 cells/ml in the control group (P = 0.007).
Conclusion: Adherence counseling and text message reminders improved adherence among HIV patients. Its adoption 
for HIV patient management is advocated.
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Introduction
HIV/AIDS clearly is one of the world’s most challenging 
pandemics and greatest health crisis today,[1] and sub‑Saharan 
Africa remains the worst affected region. In 2007, over 68% 
of all adults and 90% of all children infected with the virus 
lived in the region, while more than 76% of all deaths related 
to the virus also occurred in the region. Nigeria is one of 
the countries most affected in the region, with a national 
prevalence rate of 4.1%, while Rivers State of Nigeria is 
ranked 10th among states with a prevalence rate of 6.0%.[2] 
Efforts at controlling the epidemic witnessed the introduction 
of HAART, which has turned what was once a death sentence 
into nothing more than a chronic illness.[3] The main aim of 
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treatment with HAART is to achieve a reduction in viral load 
to undetectable levels. This allows immune reconstitution 
and leads to marked clinical improvement. It has also proven 
to prevent episodes of opportunistic infections.[4]
However, a major concern has remained adherence to 
treatment regimen. Indeed adherence is one of the key 
factors that determines the success or failure of HAART. 
It is crucial to achieving treatment goals of undetectable 
viral load, increasing CD4+ cell counts and improvement 
in the clinical condition of people living with HIV‑AIDS 
(PLHIV).[5] Adherence has been defined as the extent 
to which the patient continues the agreed upon mode 
of treatment under limited supervision.[6] In contrast, 
non‑adherence is defined as the discontinuity or cessation of 
part or all of the treatment such as dose missing, under dosing, 
overdosing or drug holidays.[7] Most experts agree that for 
best results treatment adherence to HAART therapy should 
be as high as 95%.[8,9] The Nigerian National Guidelines for 
HIV and AIDS Treatment and Care in Adolescents and 
Adults concurs with this cut off, asserting that for a patient 
to be tagged as adherent he/she must not miss more than 
one dose in ten days if on a twice daily regimen.[10]
If adherence of 95% and above is not achieved, treatment failure 
is most likely to occur. Treatment failure is typified by detectable 
viral load usually accompanied by a falling CD4+ cell count 
and ultimate deterioration in clinical response. Of all the factors 
thought to influence treatment failure, patient adherence to 
medication is the most important and most modifiable.[3] This 
underscores the need for HAART clinics to implement various 
strategies that go beyond the casual provider admonitions to 
patients to take their medication so as to help these patients 
achieve and maintain optimum adherence.[11]
Studies done in Rivers State in 2006 and 2010 showed 
adherence rates of 49.2% and 72.2%, respectively.[12,13] 
This suboptimal adherence rate has been corroborated by 
other studies done in Nigeria,[14‑16] indicating that there is 
still much to be done in terms of achieving and sustaining 
optimal levels of adherence in the country. This position is 
supported by the growing number of people on second‑line 
treatment in Nigeria.[17] Two randomized control trials carried 
out in Kenya showed that the use of weekly short message 
sending improved adherence in patients on HAART. The 
first improved adherence over a period of one year (relative 
risk [RR] 0·81, 95% CI = 0·69‑0·94; P = 0·006) and rates of 
viral suppression (RR 0·84, 95%  CI = 0·71‑0·99; P = 0·04) 
compared with the control individuals,[18] while the second 
achieved adherence of at least 90% during the 48 weeks of 
the study, compared with 40% of participants in the control 
group (P = 0.03).[19] However, a number of researchers 
have made the assertions that a combination of two or more 
interventions give far better results than a single intervention 
strategy, and that interventions targeted at non‑adherents 
give better outcomes than those that do not.[11,20,21]
This study was therefore carried out to determine the effect 
of the combination of cognitive and behavioral interventions 
(adherence counseling and text message reminders) in 
improving treatment adherence among non‑adherent HIV 
patients on HAART. The result of the study will be useful 
in examining the desirability of integrating a combination of 
adherence interventions into normal HAART clinic activity 
of antiretroviral service providers.
Materials and Methods
The study was carried out in a tertiary health care institution 
in Nigeria. The hospital is a referral centre to many health 
facilities both within and outside the state. It is a 600 bed 
hospital with several departments. It hosts one of the eight 
antiretroviral (ART) centers in the state and is funded by 
the Federal Ministry of Health. The ART clinic runs twice 
weekly and has an average of 6000 registered patients.
Eligibility criteria
Inclusion
•  HIV positive clients who had been HAART 
experienced for at least three months prior to 
commencement of the study. This was done to give 
adequate time for adherence issues if any to emerge
•  Clients who had a history of non‑adherence (adherence 
below 95%) to HAART at the time of the study, since 
it has been shown that interventions targeting the 
non‑adherent are more successful than generalized 
interventions[20]
•  Clients who owned a mobile phone or had daily access 
to a phone and were able to use the SMS (Short 
Message Sending) feature on these phones.
Exclusion
•  HIV positive clients who were HAART naive or had 
been on therapy for less than three months before the 
study
•  Clients on HAART who also had other chronic diseases 
that necessitated daily medication e.g., tuberculosis, 
hypertension. This was because of the increased pill 
burden from co‑morbidities that could introduce 
undesirable effects into the study
•   Clients on HAART who were on admission since drug 
adherence would be ensured via provider administered 
treatment.
Study design
This was an experimental study, employing a randomized 
control trial, to determine the effect of two interventions 
on adherence among non‑adherent clients on HAART.
Sample size determination
Sample size of 104 for the study was estimated using the formula 
to determine the difference between two proportions,[22] with 
expected power of 90%, using a study where proportion of 
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clients in intervention and control groups who achieved 
adherence at post‑intervention assessment were (94%) and 
(69%), respectively[23] with significance level set at 5%.
Sampling method
Purposive sampling was used to recruit participants for the 
study via announcements at the clinic’s waiting area during 
the health education sessions. Recruitment was done over 
a six‑week period and only those who met the eligibility 
criteria were enrolled into the study [Figure 1].
Randomization protocol
All enrolled participants were allocated to intervention and 
control groups via the process of randomization. The researchers 
generated study codes and random assignments using the 
randomization function of the WINPEPI (VERSION 9.7) 
statistical software.[24] Written allocations of these assignments 
with study identification codes were sealed in individual 
opaque envelopes and placed in a bag. A research assistant 
was responsible for presenting this bag of envelopes to eligible 
participants during the recruitment process and recording each 
participant’s allocation after they had opened their envelopes 
in the study register. Adherence counselors and research 
assistants were blinded to the study group allocations. Based 
on these allocations, 52 persons were assigned to Group B 
(Intervention), while 52 persons were assigned to Group A 
(Control). In order to avoid contamination between study 
and intervention groups, each group was assigned a separate 
clinic day such that throughout the course of the trial, study 
and intervention groups did not meet.
Description of intervention
Intervention group
• Cognitive intervention (Adherence counseling)
Figure 1: The consolidated standards of reporting trials (CONSORT) diagram for the study
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  One adherence counseling session per month for four 
consecutive months was conducted for each client. 
Each session lasted between 45 and 60 min. These 
sessions were facilitated by four junior resident doctors 
of the department of community medicine who were 
trained to deliver adherence counseling in line with a 
national adherence counseling training curriculum.[25] 
One counselor was assigned to a client and worked 
with that client for the duration of the intervention. 
All sessions were recorded for the purpose of providing 
feedback to counselors and ascertaining the quality 
of sessions. Each counselor made use of an adherence 
checklist to maintain a client adherence management 
chart for each client
• Behavioral intervention [SMS reminders]
  Twice a week (Monday and Thursday mornings) for the 
duration of four months, each client enrolled into the 
intervention group of the study was sent a pre‑scripted 
text message containing adherence‑related information 
and a reminder to take HAART medications. These 
messages were sent out via an Internet‑based bulk 
SMS facility known as ‘Light Edge SMS’ powered by 
Light Edge Systems (www.lightedgesystems.com). 
The researchers were responsible for sending out 
these messages. In order to ensure that these messages 
were received, two measures were put in place. Firstly, 
one of the researcher’s phone contacts was added 
to the receiver category of every message, such that 
she received the messages being sent out. Secondly, 
designated phone number contacts were sent with each 
message and study participants were encouraged to call, 
‘flash’ or send an SMS to those numbers to acknowledge 
receipt of SMS as well as indicate their need for further 
counseling or information. The researchers manned 
these phones and provided counseling support on a 
need basis via telephone. Details of all text messages 
sent and phone conversations were recorded in a log 
book developed for this purpose.
Control group – standard care
The control group received standard care only. This meant 
that they did not get any adherence counseling and SMS 
message reminders. Standard care consisted of:
•  Group health education and information on varying 
topics such as the importance of adherence, methods 
of transmission of HIV, dietary advice and nutrition 
information, as conducted by the nurses and/or 
counselors before the commencement of each clinic
•  Occasional admonitions by the doctors (during clinic 
consults) and pharmacists (during drug dispensing) 
to clients to take their medications as prescribed
•  Quarterly assessment of CD4+ results such that clients 
with decreasing CD4+ are questioned about their 
adherence and further managed based on their responses 
as to whether they are adhering to medication or not.
Outcome variables
•  Self‑reported adherence 
  This was calculated based on client self‑report of 
number of pills missed in the past seven days. The 
formula used for calculating adherence was the number 
of doses taken/number of doses prescribed × 100%.[7] 
A cut‑off of 95% was used to distinguish those who were 
adherent from those who were not. Adherence was 
assessed at recruitment (before the commencement of 
the intervention), at every monthly counseling visit 
and at the end of the intervention in the fourth month. 
The two adherence values used for comparison were 
the pre‑intervention and post‑intervention adherence 
rates in the intervention and control groups.
•  CD4+ cell count Pre‑and post‑intervention CD4+ cell 
counts were carried out for all study participants. The 
results for the intervention and control groups were 
compared to ascertain any changes in CD4 levels 
pre‑ and post‑intervention and the magnitude of such 
changes if present. CD4+ count has been shown to be 
useful as a biological measure of response to HAART 
treatment, which is dependent among other things on 
adherence to treatment.[3]
Data analysis
All data obtained from the study was entered and analysed on 
SPSS version 18.0. Data was entered, cleaned and analysed by 
the researchers with the assistance of a statistician. Risk rates 
andtests of significance using Chi‑square and Mann‑Whitney 
U tests were used to compare the intervention and control 
groups. Cohen’s effect size (w) was also calculated. Level of 
significance was set at P = 0.05.
Ethical considerations
Ethical clearance was sought and received from the Ethics 
Committee of the institution before the study commenced 
and all participants gave written informed consent by signing 
and returning a consent form prepared for this purpose.
Study limitations
•  Client self‑report as a measure of adherence is prone 
to biases such as recall bias. However, studies show 
that clients who report poor adherence are most likely 
to be telling the truth as opposed to those who claim 
good adherence.[26]
•  Use of CD4+ estimation as a proxy measure of 
adherence instead of measurement of viral load. 
However, CD4+ cell count is accepted by the national 
guidelines for HIV and AIDS treatment and care.[27]
•  Possible contamination of intervention and control 
groups through interactions outside the hospital 
environment.
Results
One hundred and four participants were enrolled for the 
study, consisting of 45 (43.3%) males and 59 (56.7%) females. 
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The mean ages of the control and intervention groups are 
35.27 ± 9.04 and 36.62 ± 11.77, respectively. There was no 
significant difference in the distribution of males and females 
into intervention and control groups (χ2 = 1.919, P = 1.919, 
P = 0.166). Similarly, the groups were comparable with regard 
to other demographic variables of age, education, marital 
status, employment and income level [Table 1].
Pre‑intervention, adherence‑related knowledge of the 
study participants was assessed. Most participants in both 
groups understood what HIV is and what its drug treatment 
entails (χ2 = 0.058, P = 0.810) but their knowledge of drug 
names was very low in both groups [Table 2]. Similarly, 
pre‑intervention median CD4+ cell counts in the control 
and intervention groups were measured and the results 
showed no significant difference among the groups.
Post‑intervention, there was significant improvement in 
knowledge of the dosage and dosing instructions of the 
antiretroviral drugs P = 0.046). The comparisons between 
the groups pre‑and post‑intervention are as shown in 
Table 3. In the same vein, results using the Intention to 
Treat Analysis (non‑response = non‑adherent) showed 
that 76.9% of those in the intervention group had achieved 
adherence to drug treatment as opposed to 55.8% in the 
control group. This difference was significant (χ2 = 5.211, 
P = 0.022). In addition, there was a small effect size 
(Cohen’s w) of 0.224 and risk ratio of 0.75 (0.55‑0.96) 
[Table 4]. Similarly, the post‑intervention median 
CD4+ cell count of the intervention group increased to 
578.0 cells/ml compared to 361.5 cells/ml recorded in the 
control group. Using Mann‑Whitney U test, the observed 
difference was significant (P = 0.007) [Table 5].
Discussion
These results highlight the association between adherence 
Table 1: Demographic profile of intervention and 
control groups










Male 19 (42.2%) 26 (57.8%) χ2=1.919
Pr=0.166Female 33 (55.93) 26 (44.07)
Age
20-29 15 (28.8%) 17 (32.7%) χ2=6.104
P=0.72930-39 22 (42.3%) 18 (34.6%)
40-49 11 (21.2%) 9 (17.3%)
50-59 4 (7.7%) 5 (9.6%)
60-69 0 (0.0%) 3 (5.8%)
Highest level of education
None 3 (5.8%) 1 (1.9%) χ2=1.533
P=0.821Primary 6 (11.5%) 8 (15.4%)
Secondary 26 (50.0%) 26 (50.0%)
Post secondary 9 (17.3%) 9 (17.3%)
Tertiary 8 (15.4%) 6 (11.5%)
No response 0 (0.0%) 2 (3.8%)
Marital Status
Single 23 (44.2%) 21 (40.4%) χ2=1.254
P=0.740Married 24 (46.2%) 25 (48.1%)
Separated/Divorced 4 (7.7%) 3 (5.8%)
Widowed 1 (1.9%) 3 (5.8%)
Employment status
Working full time 31 (59.6%) 29 (55.8%)  χ2=1.07
P=0.898Working part time 4 (7.7%) 5 (9.6%)
Unemployed 8 (15.4%) 11 (21.2%)
Looking for work 6 (11.5%) 5 (9.6%)
Full time house wife 0 (0.0%) 1 (1.9%)
Retired 1 (1.9%) 0 (0.0%)
Student 2 (3.8%) 1 (1.9%)
Income
<N10,000 15 (28.8%) 15 (28.8%) χ2=1.124
P=0.952N10,000-N29,000 14 (26.9%) 17 (32.7%)
N30,000-N49,000 4 (7.7%) 5 (9.6%)
N50,000–N99,000 4 (7.7%) 4 (7.7%)
N100,000 and above 5 (9.6%) 3 (5.8%)
No response 10 (19.2%) 8 (15.4%)
Table 2: Pre-intervention adherence-related 
knowledge (Intention to treat analysis)
Adherence 
knowledge 
Pre-intervention Test statistics 





I Know 18 (34.6) 19 (36.5) 0.042 (0.838)
I don’t know 34 (65.4) 33 (63.5)
Dosage
I know 41 (78.8) 41 (78.8) 0.000 (1.000)
I don’t know 11 (21.2) 11 (21.2)
Dosage instructions
I know 31 (59.6) 31 (59.6) 0.000 (1.000)
I don’t know 21 (40.4) 21 (40.4)
Table 3: Post-intervention adherence-related 









I know 11 (21.2) 14 (26.9) 0.474 (0.491)
I don’t know 41 (78.8) 38 (73.1)
Dosage
I know 44 (84.6) 50 (96.2) 3.983 (0.046)
I don’t know 8 (15.4) 2 (3.8)
Dosage instructions
I know 44 (84.6) 50 (96.2) 3.983 (0.046)
I don’t know 8 (15.4) 2 (3.8)
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behavior and knowledge of drug dosages and dosage 
instructions. Ogunbanjo and Heyer had in their review of 
effective interventions that improve adherence revealed that 
while cognitive interventions such as text messaging alone 
may increase adherence knowledge, they may not translate 
into changes in adherence behavior.[20] They postulated that 
a combination of both cognitive and behavioral interventions 
had greater potential to affect both knowledge and practice 
of adherence.[20] The findings of this study corroborates 
their position by showing significant difference of 20% and 
above between the intervention group who benefited from 
counseling and text message reminders and control groups 
who only had standard care. Recent studies by Chung et al. in 
Kenya using counseling and alarm devices as interventions[28] 
and those of Pop‑Eleches et al. and Lester et al. have equally 
demonstrated the positive effect of including SMS facilities 
to reinforce cognitive intervention of adherence counseling 
in order to improve adherence among HIV patients.[18,19]
Similarly, post‑intervention median CD4+ cell counts 
showed significant increase from pre‑intervention values, 
indicating an improvement in adherence and immunological 
competence in the intervention group as against the 
treatment failure usually typified by a detectable viral 
load and accompanying falling CD4+ cell count and 
ultimate deterioration in clinical response. This finding 
was in agreement with other studies such as that by Wang 
et al., which showed that an increase in adherence was 
tied to increases in mean CD4+ cell count levels and the 
prevention of opportunistic infections.[29]
The study revealed generally poor knowledge of the names 
of the ARV medication among the study participants. 
This was not totally surprising as the study was carried out 
among non‑adherent patients and their lack of interest in 
the drugs might have been responsible for their behavior. 
The technical nature of drug names, coupled with the low 
education and social status of most participants could also 
have contributed to the finding. Studies by Hulka et al. 
had demonstrated that patients who learned the name 
of their drugs had better adherence than those who did 
not.[30] This notwithstanding, adherence rates improved 
among the study participants at post‑intervention even 
when their knowledge of the drug names did not. With 
regard to drug dosages and dosing instructions, knowledge 
of participants was found not only to be high in both 
control and intervention groups at pre‑intervention, 
they improved further at post‑intervention four months 
later. This was good for ARV drug adherence and could 
have resulted from the simplicity of doses and dosing 
instructions of ARV medications. It also corroborated 
the findings by Agu et al. who evaluated treatment 
outcomes among HIV patients receiving combination 
treatment in Benin city, Nigeria.[14] However, the study 
by Wang et al. carried out in rural China revealed a lower 
knowledge of dosages and dosing instructions among the 
HIV patients receiving care.[29] The lower educational 
level of most rural residents might have been responsible 
for the difference.
Conclusion
The outcome of this study support the results from 
other studies, which highlighted that a combination 
of counseling and text message reminders significantly 
improved drug adherence as well as the CD4+ cell counts 
among non‑adherent HIV patients on HAART. Therefore, 
integrating drug adherence assessment as part of routine 
HIV clinic consultations and adherence counseling and text 
messaging to address adherence challenges among PLHIV is 
advocated.
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